Product Program year 2025 Source: CMS Open Payments

Gomekli

Drug

NDC 82448-130-42

Open in the dashboard

General payments

$80,012

85 payments

Research payments

$0

0 payments

Through program year 2025, $80,012 in general payments and $0 in research payments were reported against Gomekli.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $80,012 85

Breakdown

Who paid General payments · program year 2025
  1. SpringWorks Therapeutics, Inc. $80,012 85 payments
Top recipients General payments · program year 2025
  1. Hospital Of The Univ Of Penna Teaching hospital · PA $11,500 14% · 3 payments
  2. Timothy Gershon Pediatrics · Chapel Hill, NC $10,814 14% · 4 payments
  3. Mina Lobbous Neurology · Birmingham, AL $8,122 10% · 2 payments
  4. Valley Childrens Hospital Teaching hospital · CA $7,500 9% · 3 payments
  5. Angela Hirbe Medical Oncology · Saint Louis, MO $7,367 9% · 3 payments

The top 5 of 60 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurology Psychiatry & Neurology $12,622 30% · 15 practitioners
  2. Pediatrics $10,851 26% · 3 practitioners
  3. Medical Oncology Internal Medicine $7,367 18% · 1 practitioner
  4. Pediatric Hematology-Oncology Pediatrics $4,358 10% · 9 practitioners
  5. Anatomic Pathology Pathology $3,010 7% · 1 practitioner

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $11,500 14% · 1 recipient
  2. Missouri $11,298 14% · 5 recipients
  3. North Carolina $10,814 14% · 1 recipient
  4. Alabama $10,622 13% · 2 recipients
  5. Texas $8,700 11% · 17 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

85 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record